ecancermedicalscience

Case Report

Uterine leiomyosarcoma with central nervous system metastases

5 Mar 2015
Carina Meira Abrahão, Fernando Cotait Maluf

Leiomyosarcoma (LMS) is a rare tumour and comprises 2–3% of all malignant uterus neoplasms [1]. Leiomyosarcoma is characterised by aggressive behaviour, high recurrence rates, and poor overall survival, despite multimodal treatment [3]. Surgery is the main treatment and consists of total abdominal hysterectomy. A randomised trial consisting of 224 patients diagnosed with uterine sarcomas stage I and II showed that adjuvant radiotherapy improves locoregional control. The role of adjuvant chemotherapy is still unclear [1]. Unfortunately, roughly 50% of patients with organ-confined disease will usually develop distant metastasis to lung, peritoneum, liver, pelvic, and para-aortic lymph nodes. Brain metastases are extremely rare [5].

Related Articles

Badira Cheriyalinkal Parambil, Girish Chinnaswamy, Maya Prasad, Venkata Rama Mohan Gollamudi, Ajay Puri, Ashish Gulia, Sajid Qureshi, Prakash Nayak, Manish Pruthi, Siddhartha Laskar, Nehal Khanna, Jifmi Jose Manjali, Amit Janu, Sneha Shah, Nilendu Purandare, Mukta Ramadwar, Poonam Panjwani, Bharat Rekhi, Pallavi Rane, Shripad Banavali
Muisi A Adenekan, Joseph B Minari, Ayodeji Adefemi, Gbenga Olorunfemi, Ayomide I Fayinto, Adebayo Sekumade, Temitope V Adekanye, Adeyemi A Okunowo, Kehinde S Okunade
Nairica Eurico Rebello, Anita Spadigam, Anita Dhupar, Jochima Cota, Vikas Dhupar